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Abstract 
 
Cytochrome P450 are fundamental proteins to the metabolism of drugs and other relevant 
processes. through a combination of text mining and network analysis of the P450 literature we 
mapped the emergence and evolution of the biomedical research communities working on this 
family of proteins. Our results suggest that the historical research communities that worked on 
P450 emerged and were organized mainly around methodological achievements like the induction 
of animal liver microsomal P450 by drugs, the use of chemical inhibitors of P450 enzymes in in-
vitro metabolism studies and the development of E. coli expression systems. We found clear 
evidence that P450 research indeed constitutes a material scientific culture, as we discuss in the 
text. 
 
 
Introduction 
 
Cytochrome P450 are hemoproteins that absorb light at 450 nm, when reduced in the presence of 
carbon monoxide.[1] This family of enzymes is found in all the three domains (Eukarya, Archaea, 
and Bacteria) and one giant virus species.[2] Moreover, P450 enzymes participate in several 
metabolic processes, such as those of fatty acid, eicosanoid, and vitamin A and D metabolism, as 
well as metabolism of xenobiotics like pharmaceuticals and carcinogens.[3] Not surprisingly then, 
P450 proteins are studied by a plethora of disciplines including cancerology, biochemistry, 
biotechnology, enzymology, physiology, pharmacology, and toxicology.[4-6] P450 research is a 
consolidated R&D field with over fifty years of history.[4-6] Despite the diversity of disciplines 
working on P450, it has been suggested the existence of a large and historically-based research 
community of P450.[4-6] Scientific leaderships, problems, methodologies, and fundamental 
achievements have been pointed out for this regard.[4-6] However, it is unknown how this putative 
research community has been organized, and how this community evolves in terms of literature 
networks, from a literature network perspective. These questions are quite relevant as P450 
research is simultaneously a very specialized, extensive, and diverse research topic. To provide a 
fresh insight on the relevance of analyzing the network of papers on P450 research, it is important 
to provide a brief background on the studies on the structure of biomedical research.  
 
Previous research on the structures and evolution of biomedical knowledge 
 
Previously, it has been described the structure and evolution of the biomedical and clinical 
knowledge on specific diseases (Anthrax,[7] cancers,[8, 9] ebola[10] and HIV/AIDS[11]) from a 
literature network perspective. At the core of these studies there is the methodological concept of 
research fronts, which are sub-networks of papers whose citations are “dense but between which 
they are sparse” produced by different research communities that work on specific top ics with 
defined methodologies and achievements.[12] In general, the evolution and organization of the 
research on diseases is leaded by a reductionist process of specializations.[7, 8, 10-12] That is, 
the older research front is normally related to the study of the disease at the epidemiological 
(populations) to a systemic (patient) level.[7, 8, 10-12] This first research front provides the clinical 
description of the disease, i.e., the explanandum to be explained in a reductionist fashion by the 
subsequent research fronts.[7, 8, 10-12] The following research fronts tend to be specialized in the 
study of cellular/biomolecular process, mechanism or structures that conform the biomedical 
explanations of the disease.[7, 8, 10-12]  
 
P450 biomedical research is quite different to the previously studied instances, as this family of 
proteins is a central element for the explanation of several physiological phenomena of medical 
importance (explananda), like drug metabolism, chemical toxicity or diseases such as P450 
oxidoreductase deficiency.[3-6]  On the other hand, P450 proteins, as object of study, are mainly 
investigated in terms of diversity,[13] mechanisms and structure.[14] We expected that the 
organization and evolution of P450 research would be leaded by these two objectives: the search 
for explanations of macroscopic phenomena via P450 enzymes and the study of the mechanisms, 
diversity and structure of the different P450 enzymes.  
   
Objective 
 
Accordingly, through a combination of text mining and network analysis we attempt to map the 
emergence and evolution of the biomedical research communities working on P450 proteins.   
 
Methodology 
 
The methodology was previously successfully used to analyze the organization of the research 
fronts in HIV/AIDS,[11] ebola[10] and cancer-nanotechnology[15, 16]: 
 
1. A search of papers on the cytochrome P450 was performed in the Web of Science Core 
Collection[17] during March, 2017.The search criteria were the following: TITLE: (P450 or 
P-450) AND TITLE: (drug or treat* or pharm* or therap* or patient or clinical or human). 
Timespan: All years. Indexes: SCI-EXPANDED, SSCI, A&HCI, CPCI-S, CPCI-SSH, BKCI-
S, BKCI-SSH, ESCI. 6,527 papers were found. 
2. A network model was built with the papers found in the Web of Science by using the 
software HistCite.[18] Then, the network model was analyzed and visualized with 
Cytoscape.[19] The network model consisted of 4,741 nodes and 31,649 edges. Then, the 
nodes (papers) with a minimal in-degree of 4 (1,847 nodes) were selected. It is important to 
mention that this sub-network of 1,847 nodes received the 91 percent of the inter-citations 
(28,899 of 31,649). 
3. Cluster analysis based on the Newman modularity[20] was performed on the core 
subnetwork using Clust&see,[21] a Cystoscape plug-in. This analysis divided the sub-
network of citation in several research fronts or clusters of papers. The network clusters are 
defined by Newman as “groups of vertices within which connections are dense but between 
which they are sparse.[20]” 
4. The sub-network was displayed by using the “yFiles organic” algorithm[21], which is based 
on the force-directed layout. 
5. The content of the identified research fronts -the abstract of their papers- was analyzed with 
KH Coder[21], a software for quantitative content analysis.  
 
Results 
 
The network model 
 
A network model of 1,848 high cited papers on P450 was built (Figure 1). The papers of this model 
received the 91 percent of the inter-citations (28,899 of 31,649) from the research topic. Clust&see 
identified 11 Research fronts. One of these fronts, the sixth largest, was found to be too general to 
be considered relevant, according to our text mining results. The research fronts (Figures 1 and 2) 
were named according to the results of the text mining (Table 1) and title and abstract of the top 
three papers with the highest indegree of each research front (Table 1).  
 
Figure 2 offers a synthesized view of the organization and evolution of P450 research. This figure 
shows the main interactions among the 10 research fronts which are displayed according to the 
average year of publication of their papers. Our results suggest that the most of P450 research is 
organized around research instruments (research fronts 1-3, 6 and 7) whereas research front 4, 5, 
8, 9 and 10 are organized around the study of specific molecular mechanism.  
 
Research fronts related to research instruments 
 The three biggest research fronts (research fronts 1, 2 and 3) emerged in three well differentiated 
periods of time (Figure 3), i.e., they are related to three different stages in the history of P450 
research. Research front 2, the oldest and second biggest, is related to the induction of P450 and 
its subsequent purification from rat liver microsomes (Table 1).  Research front 1, the biggest 
(Table 1), whose papers were on average published one decade later (Figure 2 and 3), is related 
to the use of chemical inhibitors of P450 in in-vitro metabolism studies (Table 1). Research front 3, 
the most recent among the research fronts, is related to the development of E. coli expression 
systems of P450 for large-scale isolation to perform structure/function analyses (Table 1). 
Research front 6 is related to the use of bacteriophage libraries to clone the DNA coding sequence 
of P450 forms. Finally, research front 7 is related to the use of human hepatocytes as a tool for 
evaluating new molecular entities as inducers of P450 enzymes.  
 
Research fronts related to the study of molecular mechanisms 
 
Research fronts related to the study of molecular mechanisms are smaller and more peripheral 
than the methodological research fronts. The biggest research front of this class is research front 4 
(Table 1) which is related to the study of the role of P450 in the activation of procarcinogens (Table 
1). Research front 4 is strongly attached to research fronts 1 and 2 (Figure 2) and emerged in an 
intermediate period between the fall of research front 2 and the emergence of research front 1 
(Figure 2 and 3). Research front 5 is related to the study of  P450 enzymes that metabolize 
arachidonic acid, which is converted into more than 100 eicosanoid metabolites. Research front 8, 
the second oldest among all the research fronts (Figures 2 and 3), is related to the study of the 
aromatase enzyme, a member of the cytochrome P450 superfamily, that have an important role in 
steroidogenesis. Research front 9 is related to the study of the pharmacological activation of anti-
cancer drugs by P450 enzymes. Finally research front 10 is related to the study of  P450 
oxidoreductase (POR) mutations that produce diseases like Antley-Bixler syndrome with abnormal 
genitalia and POR deficiency, a particular form of congenital adrenal hyperplasia.  
 
Discussion 
 
P450 research as a material scientific culture 
 
The most relevant implication of our results is the material nature of P450 research as a scientific 
culture (For a deeper discussion on material scientific cultures please see [23]), ruled by clearly 
identified conditions of instrumentality (“constrains that delimit the allowable form and function of 
laboratory machines themselves”[23]). The classical examples of material scientific cultures are the 
traditions of instruments in microphysics which were detailed studied by Peter Galison, for whom 
those two cultures are organized around the building and use of bubble chambers to form images 
that would serve as evidence for a new particle; and those employing counting devises arrayed 
around the particle collision event itself that gather data to make statistical arguments for the 
existence of a particle.[24, 25] In the case of the biomedical research on P450 enzymes, the 
conditions of instrumentality are (1) the induction of P450 enzymes in animal model livers, (2) the 
use of chemical inhibitors in vitrometabolism studies and (3) the use of heterologous expression 
systems to produce human P450 enzymes (See table 1). These conditions of instrumentality in 
P450 research set out the conditions under which the instruments will be judged or assessed. For 
example, the criteria that establish under what conditions vitrometabolism, animal model or 
hepatocytes would more useful to predict specific aspects of the metabolism of a drug candidate in 
patients. On the other hand, our results identified research fronts fronts 4, 5, 8-10) that are related 
to the mechanistic explanation of macro/mesoscopic phenomenon (diseases, metabolism of 
steroids, drugs and arachidonic acid). However, these fronts represent only 29% of our network 
model.  
 
How research instruments would lead to the emergence of P450 research fronts 
 
A useful frame to understand how research instruments would lead to the emergence of the 
research fronts in P450 research, is the model of scientific progress proposed by Thomas 
Kuhn.[26] An interpretation of Kunnian ideas is that science is a complex social system that 
cyclically undergo a sequence of phases, namely: normal science (a period of standardization of 
the scientific practice and high productivity), anomalies (the standards are questioned and the 
productivity reachs its maximum peak), crisis (abandon of the standards and a fall in the 
productivity)  and paradigm shift in which new standards, approached and/or methodologies are 
established.[27] Figure 3 shows how most of the identified research fronts clearly exhibit stages of 
rising, stagnation and fall. In the same vein, the succession of the research fronts would be related 
to paradigm shifts. Particularly, our results suggest that the emergence of the research fronts in 
P450 research is related to research instruments that opened the doors to new way of investigating 
P450 proteins. The narrative of how this research instruments conducted to the emergence of 
research fronts would be as follows:  
 
The research front 2, the oldest, is related to the discovery of P450 which was spectrally detected 
(but not yet discovered), for the first time, in rat liver microsomes.[28] However, according to our 
results the class of instruments that led to the emergence of the first research front was the 
induction of rat liver microsomal P450 by drugs and other chemical compounds, representing an 
important contribution for the the purification of microsomal P450 (Table 1). This methodology led 
to the discovery of several P450 isozymes with different metabolism roles.[29] Simultaneously to 
the drop of front 2, the research front 1 arose (Figures 2 and 3). The class of instruments that 
explains the emergence of front 1 was the use of chemical inhibitors of P450 enzymes in in-vitro 
metabolism studies (Table 1). This methodological approach furthered the identification of P450 
enzymes involved in the metabolism of drug candidates and the prediction of drug–drug 
interactions.[30] Knowledge of P450  induction, and inhibition is currently a fundamental part of 
drug development process.[31] Few years after the emergence of front 1, front 3 emerged (Figures 
2 and 3). The emergence of front 3 is derived from the development of E. coli heterologous 
expression systems to study P450 (Table 1). These instruments allowed to obtain high quantities 
of P450 and to perform site-directed mutagenesis studies.[32] Importantly, E. coli expression 
systems allowed the crystallization of eukaryotic P450, which are intrinsic membrane proteins, by 
expression of P450 enzymes without the trans-membrane leader sequence.[33] These three 
research fronts represent the 56% of papers of the network model. The successive emergence of 
these fronts would represent the paradigm shifts in the history of P450 research. On the other 
hand, the research fronts 6 and 7, which are also related to research instruments (the  use of 
bacteriophage lambda libraries to clone P50 enzymes and the use of human hepatocytes), are 
much smaller to be related to fundamental changes in the trajectory of P450 research.  
 
Milestones in P450 research  
 
Michael R. Waterman, a veteran of P450 research, and his collaborator David C. Lamb elaborated 
a timeline of the most relevant milestones in P450 research, which include discoveries on bacterial 
P450 enzymes.[33] It is important to notice that our analysis was focused only on the biomedical 
research part of this topic. However, a significant part of the milestone pointed by Waterman and 
Lamb are methodological achievements, instead of discoveries which strength the idea that P450 
research is a material scientific culture (organized around instruments classes). Moreover, some of 
these milestones pointed out by Waterman and Lamb[33] are related to the emergence of research 
fronts 2 and 3: “Multiplicity of P450s confirmed” in 1975 and 1976 and mainly “resolution of human 
P450 enzymes” in 1985 and 1986 are related to front 2 whereas  “development of E. coli 
expression systems to produce high levels of P450 for structure/function analysis” in 1991 and  
“first eukaryotic P450 structure (CYP2C5)” in 2000 are related to front 3.  
 
Interestingly, Furge and Guengerich, the last another veteran of P450 research, agree with our 
results in terms of what are the big topics and milestone in P450 research: purification of P450 
enzymes, inhibition of P450 and the use of expression systems.[4]  
 
Conclusion 
 
For the first time, the network structure and dynamics of P450 biomedical research has been 
elucidated. We showed how well-defined conditions of instrumentality (class of instruments) are at 
the core of the emergence and evolution of the leading research communities that work on this 
family of enzymes. Further investigation is needed if a deeper understanding of how these class of 
research family instruments have evolved and impacted the most recent research on P450, is to be 
achieved.    
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 Figure 1. The ten research fronts in the network model. The model is displayed by using the “spring embedded” algorithm. The color of 
nodes (representing the papers) indicates which research front they belong to.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2. Main interactions among the research fronts. Each node represents one of the ten research research fronts. The edges 
represent the sum of the inter-citations between two research fronts. Only the interactions formed by a minimal of 500 inter-citations or 
the largest interaction of each research front are shown. Research fronts are displayed according to the average year of publication of 
their papers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Number of papers per year for each of the research fronts. 
  
 
Table 1. Top 10 distinctive worlds and list of the three papers with the highest indegree within each research front. 
 
Front 1 “Inhibitors of P450” 
Top 10 most distinctive 
words 
Papers with the highest indegree 
inhibitor 
Shimada T, Yamazaki H, Mimura M, Inui Y, Guengerich FP. Interindividual variations 
in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, 
carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 
30 Caucasians. Journal of Pharmacology and Experimental Therapeutics. 1994 Jul 
1;270(1):414-23. 
CYP 
vitro 
inhibition Newton DJ, Wang RW, Lu AY. Cytochrome P450 inhibitors. Evaluation of specificities 
in the in vitrometabolism of therapeutic agents by human liver microsomes. Drug 
Metabolism and Disposition. 1995 Jan 1;23(1):154-8. 
microsome 
liver 
microM Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi LC, 
Gelboin HV, Miners JO. Specificity of substrate and inhibitor probes for human 
cytochromes P450 1A1 and 1A2. Journal of Pharmacology and Experimental 
Therapeutics. 1993 Apr 1;265(1):401-7. 
drug 
CYP2D6 
metabolism 
   Front 2 “Purification-Induction of P450” 
Top 10 most distinctive 
words 
Papers with the highest indegree 
rat 
Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ. 
Characterization of rat and human liver microsomal cytochrome P-450 forms involved 
in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug 
metabolism. Journal of Biological Chemistry. 1986 Apr 15;261(11):5051-60. 
purify 
form 
gel Watkins PB, Wrighton SA, Maurel P, Schuetz EG, Mendez-Picon G, Parker GA, 
Guzelian PS. Identification of an inducible form of cytochrome P-450 in human liver. 
Proceedings of the National Academy of Sciences. 1985 Sep 1;82(18):6310-4. 
dodecyl 
purification 
sodium Guengerich FP, Dannan GA, Wright ST, Martin MV, Kaminsky LS. Purification and 
characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, 
catalytic, and immunochemical properties and inducibility of eight isozymes isolated 
from rats treated with phenobarbital or. beta.-naphthoflavone. Biochemistry. 1982 Nov 
1;21(23):6019-30. 
designate 
electrophoretic 
p-450nf 
   Front 3 “E. Coli xpression system”  
Top 10 most distinctive 
words 
Papers with the highest indegree 
active 
Gillam EM, Baba T, Kim BR, Ohmori S, Guengerich FP. Expression of modified 
human cytochrome P450 3A4 in Escherichia coli and purification and reconstitution of 
the enzyme. Archives of Biochemistry and Biophysics. 1993 Aug 15;305(1):123-31. 
coli 
Escherichia 
bacterial Yano JK, Wester MR, Schoch GA, Griffin KJ, Stout CD, Johnson EF. The structure of 
human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 
2.05-Å resolution. Journal of Biological Chemistry. 2004 Sep 10;279(37):38091-4. 
membrane 
oxidation 
site 
Sandhu P, Guo ZY, Baba T, Martin MV, Tukey RH, Guengerich FP. Expression of 
modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, 
spectral characterization, and catalytic activities of the enzyme. Archives of 
Biochemistry and Biophysics. 1994 Feb 1;309(1):168-77. 
nadph-p-450 
3A4 
structure 
   Front 4 “Carcinogens” 
Top 10 most distinctive 
words 
Papers with the highest indegree 
carcinogen Guengerich FP, Shimada T. Oxidation of toxic and carcinogenic chemicals by human 
cytochrome P-450 enzymes. Chemical research in toxicology. 1991 Jul;4(4):391-407. 
1A1 
hydrocarbon 
pyrene Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR. 
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. 
Cancer research. 1996 Jul 1;56(13):2979-84. 
lung 
activation 
aromatic Rendic S, Carlo FJ. Human cytochrome P450 enzymes: a status report summarizing 
their reactions, substrates, inducers, and inhibitors. Drug metabolism reviews. 1997 
Jan 1;29(1-2):413-580. 
carcinogenic 
DNA 
sample 
   Front 5 “Arachidonic acid and brain” 
Top 10 most distinctive 
words 
Papers with the highest indegree 
arachidonic Daikh BE, Lasker JM, Raucy JL, Koop DR. Regio-and stereoselective epoxidation of 
arachidonic acid by human cytochromes P450 2C8 and 2C9. Journal of 
Pharmacology and Experimental Therapeutics. 1994 Dec 1;271(3):1427-33. 
brain 
cortex 
epoxygenase Ravindranath V, Anandatheerthavarada HK, Shankar SK. Xenobiotic metabolism in 
human brain—presence of cytochrome P-450 and associated mono-oxygenases. 
Brain research. 1989 Sep 4;496(1):331-5. 
important 
member 
cloning Nebert DW, Russell DW. Clinical importance of the cytochromes P450. The 
Lancet. 2002 Oct 12;360(9340):1155-62. endogenous 
cerebellum 
epoxyeicosatrienoic 
   Front 6 “Bacteriophage library” 
Top 10 most distinctive 
words 
Papers with the highest indegree 
bacteriophage Umbenhauer DR, Martin MV, Lloyd RS, Guengerich FP. Cloning and sequence 
determination of a complementary DNA related to human liver microsomal 
cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry. 1987 Feb 
1;26(4):1094-9. 
mephenytoin 
p-450mp 
tryptic 
Beaune PH, Dansette PM, Mansuy D, Kiffel L, Finck M, Amar C, Leroux JP, Homberg 
JC. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced 
hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the 
drug. Proceedings of the National Academy of Sciences. 1987 Jan 1;84(2):551-5. multigene 
hydroxylate 
tolbutamide 
Ged C, Umbenhauer DR, Bellew TM, Bork RW, Srivastava PK, Shinriki N, Lloyd RS, 
Guengerich FP. Characterization of cDNAs, mRNAs, and proteins related to human 
liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. Biochemistry. 1988 
Sep 1;27(18):6929-40. 
closely 
coding 
similarity 
   Front 7 “Induction of P450 in hepatocytes” 
Top 10 most distinctive 
words 
Papers with the highest indegree 
hepatocyte 
Pichard L, Fabre IS, Fabre GE, Domergue JA, Saint Aubert BE, Mourad GE, Maurel 
PA. Cyclosporin A drug interactions. Screening for inducers and inhibitors of 
cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes 
and in liver microsomes. Drug Metabolism and Disposition. 1990 Sep 1;18(5):595-
606. 
inducer 
maintain 
rifampicin Diaz D, Fabrev I, Daujat M, Saint Aubert B, Bories P, Michel H, Maurel P. Omeprazole 
is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. 
Gastroenterology. 1990 Sep 30;99(3):737-47. 
culture 
primary 
induction Madan A, Graham RA, Carroll KM, Mudra DR, Burton LA, Krueger LA, Downey AD, 
Czerwinski M, Forster J, Ribadeneira MD, Gan LS. Effects of prototypical microsomal 
enzyme inducers on cytochrome P450 expression in cultured human hepatocytes. 
Drug Metabolism and Disposition. 2003 Apr 1;31(4):421-31. 
day 
phenobarbital 
prototypical 
   Front 8 “Aromatase and steroid metabolism” 
Top 10 most distinctive 
words 
Papers with the highest indegree 
aromatase Thompson EA, Siiteri PK. The involvement of human placental microsomal 
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